REFERENCES
- Basak GW, Drozd-Sokołowska J, Wiktor-Jedrzejczak W. Update on the incidence of metamizole sodium-induced blood dyscrasias in Poland. J Int Med Res. 2010;38:1374–1380.
- Hedenmalm K, Spigset O. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol. 2002;58:265–274.
- Ibáñez L, Vidal X, Ballarín E, Laporte JR. Agranulocytosis associated with dipyrone (metamizol). Eur J Clin Pharmacol. 2005;60:821–829.
- Yetgin S, Ozyürek E, Aslan D, Cetin M. Metamizole sodium-induced severe aplastic anemia and its recovery with a short-course steroid therapy. Pediatr Hematol Oncol. 2004;21:343–347.
- Jurczyszyn A, Engel A, Bazan-Socha S, Czepiel J, Biesiada G, Skotnicki AB. Bone marrow suppression with plasma cell leukemia like reaction complicated by macrophage activation syndrome after metamizole overuse. Pol Arch Med Wewn. 2013;123:257–258.
- Heit WF. Hematologic effects of antipyretic analgesics: Drug-induced agranulocytosis. Am J Med. 1983;75:65–69.
- Atrah HI, Davidson RJL. Mechanism of action of intravenous immunoglobulin in immune-mediated cytopenias. J Clin Pathol. 1988;41:1249–1255.